| Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study A Tefferi, E Rumi, G Finazzi, H Gisslinger, AM Vannucchi, F Rodeghiero, ... Leukemia 27 (9), 1874-1881, 2013 | 812 | 2013 |
| Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: an international study T Barbui, J Thiele, F Passamonti, E Rumi, E Boveri, M Ruggeri, ... Journal of clinical oncology 29 (23), 3179-3184, 2011 | 582 | 2011 |
| Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites B Streubel, I Simonitsch-Klupp, L Müllauer, A Lamprecht, D Huber, ... Leukemia 18 (10), 1722-1726, 2004 | 440 | 2004 |
| A prognostic model to predict survival in 867 World Health Organization–defined essential thrombocythemia at diagnosis: a study by the International Working Group on … F Passamonti, J Thiele, F Girodon, E Rumi, A Carobbio, H Gisslinger, ... Blood, The Journal of the American Society of Hematology 120 (6), 1197-1201, 2012 | 326 | 2012 |
| Mutations in apoptosis genes: a pathogenetic factor for human disease L Müllauer, P Gruber, D Sebinger, J Buch, S Wohlfart, A Chott Mutation Research/Reviews in Mutation Research 488 (3), 211-231, 2001 | 294 | 2001 |
| Gelsolin: a candidate for suppressor of human bladder cancer M Tanaka, L Müllauer, Y Ogiso, H Fujita, S Moriya, K Furuuchi, ... Cancer research 55 (15), 3228-3232, 1995 | 247 | 1995 |
| BRAFV600E mutant protein is expressed in cells of variable maturation in Langerhans cell histiocytosis F Sahm, D Capper, M Preusser, J Meyer, A Stenzinger, F Lasitschka, ... Blood, The Journal of the American Society of Hematology 120 (12), e28-e34, 2012 | 244 | 2012 |
| Genome-wide transcriptional response to 5-aza-2′-deoxycytidine and trichostatin a in multiple myeloma cells G Heller, WM Schmidt, B Ziegler, S Holzer, L Müllauer, M Bilban, ... Cancer research 68 (1), 44-54, 2008 | 220 | 2008 |
| Essential thrombocythemia versus early primary myelofibrosis: a multicenter study to validate the WHO classification J Thiele, HM Kvasnicka, L Müllauer, V Buxhofer-Ausch, B Gisslinger, ... Blood, The Journal of the American Society of Hematology 117 (21), 5710-5718, 2011 | 218 | 2011 |
| Masked polycythemia vera (mPV): results of an international study T Barbui, J Thiele, H Gisslinger, G Finazzi, A Carobbio, E Rumi, ... American journal of hematology 89 (1), 52-54, 2014 | 193 | 2014 |
| Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem-and progenitor cells in acute myeloid leukemia (AML) H Herrmann, K Blatt, J Shi, KV Gleixner, S Cerny-Reiterer, L Müllauer, ... Oncotarget 3 (12), 1588, 2012 | 179 | 2012 |
| Image-based ex-vivo drug screening for patients with aggressive haematological malignancies: interim results from a single-arm, open-label, pilot study B Snijder, GI Vladimer, N Krall, K Miura, AS Schmolke, C Kornauth, ... The Lancet Haematology 4 (12), e595-e606, 2017 | 169 | 2017 |
| A comparative study on demographic, hematological, and cytogenetic findings and prognosis in acute myeloid leukemia with and without leukemia cutis H Agis, A Weltermann, C Fonatsch, O Haas, G Mitterbauer, L Müllauer, ... Annals of hematology 81, 90-95, 2002 | 153 | 2002 |
| Aggressive B-cell lymphomas in patients with myelofibrosis receiving JAK1/2 inhibitor therapy E Porpaczy, S Tripolt, A Hoelbl-Kovacic, B Gisslinger, Z Bago-Horvath, ... Blood, The Journal of the American Society of Hematology 132 (7), 694-706, 2018 | 152 | 2018 |
| Aberrant expression of CD30 in neoplastic mast cells in high-grade mastocytosis K Sotlar, S Cerny-Reiterer, K Petat-Dutter, H Hessel, S Berezowska, ... Modern Pathology 24 (4), 585-595, 2011 | 146 | 2011 |
| Idiopathic cytopenia of undetermined significance (ICUS) versus low risk MDS: the diagnostic interface F Wimazal, C Fonatsch, R Thalhammer, I Schwarzinger, L Müllauer, ... Leukemia research 31 (11), 1461-1468, 2007 | 146 | 2007 |
| Review of cancer treatment with immune checkpoint inhibitors: Current concepts, expectations, limitations and pitfalls C Thallinger, T Füreder, M Preusser, G Heller, L Müllauer, C Höller, ... Wiener Klinische Wochenschrift 130, 85-91, 2018 | 144 | 2018 |
| B-cell deficiency and severe autoimmunity caused by deficiency of protein kinase C δ E Salzer, E Santos-Valente, S Klaver, SA Ban, W Emminger, ... Blood, The Journal of the American Society of Hematology 121 (16), 3112-3116, 2013 | 144 | 2013 |
| Plasmacytoid dendritic cells express TRAIL and induce CD4+ T-cell apoptosis in HIV-1 viremic patients G Stary, I Klein, S Kohlhofer, F Koszik, T Scherzer, L Müllauer, H Quendler, ... Blood, The Journal of the American Society of Hematology 114 (18), 3854-3863, 2009 | 140 | 2009 |
| Diagnostic and subdiagnostic accumulation of mast cells in the bone marrow of patients with anaphylaxis: monoclonal mast cell activation syndrome K Sonneck, S Florian, L Müllauer, F Wimazal, M Födinger, WR Sperr, ... International archives of allergy and immunology 142 (2), 158-164, 2007 | 139 | 2007 |
Matthias PreusserMedical University of ViennaVerified email at meduniwien.ac.at
